{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:34:18Z","timestamp":1789403658705,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["21240050"],"award-info":[{"award-number":["21240050"]}]},{"name":"World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitronics"},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology (MEXT)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jconrel.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T02:18:45Z","timestamp":1376705925000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Redox nanoparticle therapeutics to cancer \u2014 increase in therapeutic effect of doxorubicin, suppressing its adverse effect"],"prefix":"10.1016","volume":"172","author":[{"given":"Toru","family":"Yoshitomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.08.011_bb0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0010","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1073\/pnas.1106645108","article-title":"Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells","volume":"108","author":"Jinushi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2007.05.088","article-title":"Drug resistance to 5-FU linked to reactive oxygen species modulator 1","volume":"359","author":"Hwang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0030","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","article-title":"Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0035","first-page":"27","article-title":"Involvement of NF-kappaB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells","volume":"28","author":"Oiso","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0040","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fct.2010.04.007","article-title":"New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients","volume":"48","author":"Granados-Principal","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0300-483X(99)00039-6","article-title":"Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture","volume":"134","author":"DeAtley","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0050","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-0829-3","article-title":"Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy","volume":"10","author":"Wang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00280-003-0759-9","article-title":"Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine","volume":"53","author":"Wang","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0060","first-page":"947","article-title":"Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics","volume":"30","author":"Wang","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2005.06.039","article-title":"The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-kappaB","volume":"229","author":"Kokura","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0070","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cncr.20898","article-title":"Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice","volume":"103","author":"Suy","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0075","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1248\/bpb.18.1572","article-title":"A novel spin probe with long life in vivo for ESR imaging","volume":"18","author":"Yoshioka","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1523-1755.2005.00392.x","article-title":"Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat","volume":"68","author":"Welch","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcb.1160","article-title":"Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cells","volume":"82","author":"Monti","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0090","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bcp.2004.02.005","article-title":"4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells","volume":"67","author":"Alpert","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0095","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/bm801278n","article-title":"Design of core\u2013shell-type nanoparticles carrying stable radicals in the core","volume":"10","author":"Yoshitomi","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0100","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1021\/bc900214f","article-title":"pH-sensitive radical-containing-nanoparticle (RNP) for the l-band-EPR imaging of low pH circumstances","volume":"20","author":"Yoshitomi","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2217\/nnm.11.13","article-title":"Nitroxyl radical-containing nanoparticles for novel nanomedicine against oxidative stress injury","volume":"6","author":"Yoshitomi","year":"2011","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4155\/tde.11.153","article-title":"Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery","volume":"3","author":"Nagasaki","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0120","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1016\/j.biomaterials.2011.07.024","article-title":"The use of nitroxide radical-containing nanoparticles coupled with piperine to protect neuroblastoma SH-SY5Y cells from Abeta-induced oxidative stress","volume":"32","author":"Chonpathompikunlert","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4155\/tde.11.27","article-title":"Chemical nanotherapy: nitroxyl radical-containing nanoparticle protects neuroblastoma SH-SY5Y cells from Abeta-induced oxidative stress","volume":"2","author":"Chonpathompikunlert","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2217\/nnm.12.2","article-title":"Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage","volume":"7","author":"Chonpathompikunlert","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0135","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1016\/j.biomaterials.2011.07.014","article-title":"The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles","volume":"32","author":"Yoshitomi","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0140","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1227\/NEU.0b013e31820c02d9","article-title":"Newly synthesized radical-containing nanoparticles enhance neuroprotection after cerebral ischemia-reperfusion injury","volume":"68","author":"Marushima","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0145","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0150","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.freeradbiomed.2007.02.030","article-title":"The chemistry and biology of nitroxide compounds","volume":"42","author":"Soule","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2013.08.011_bb0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","article-title":"Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species","volume":"119","author":"Pham","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.gastro.2012.06.043","article-title":"An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice","volume":"143","author":"Vong","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2013.08.011_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5849(00)00378-6","article-title":"Modulation of inflammation by reactive oxygen species: implications for aging and tissue repair","volume":"30","author":"Khodr","year":"2001","journal-title":"Free Radic. Biol. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913004690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913004690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:28:07Z","timestamp":1759159687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913004690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0168365913004690"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.08.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox nanoparticle therapeutics to cancer \u2014 increase in therapeutic effect of doxorubicin, suppressing its adverse effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}